Home
/ Kaleo
/ Competitors

Kaleo Competitors and Similar CompaniesClear all

Kaleo's competitors and similar companies include TRB Chemedica, Nobelpharma, Cosmo Pharmaceuticals and Kaken Pharmaceutical.

	Kaleo Kaléo is a company that specializes in human factors engineering and drug-device combination product development.	TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.	Nobelpharma Nobelpharma (ノーベルファーマ) is a pharmaceutical company that is engaged in the research and development of medicines and medical devices.	Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.	Kaken Pharmaceutical Kaken Pharmaceutical is a company providing pharmaceuticals and medical devices in the orthopedics and dermatology fields.
Founding Date	Founding Date 2005	Founding Date 1980	Founding Date 2003	Founding Date 1997	Founding Date 1948
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech healthtech medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma
Locations	Locations Richmond, US HQ	Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more	Locations Chuo City, JP HQ	Locations Dublin, IE HQ	Locations Bunkyo City, JP HQ
Employees	Employees 1222% decrease	Employees 900	Employees 269	Employees 321	Employees 1,135
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €104.2m (FY, 2025)	Revenue (est.) ¥94b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €40.4m (FY, 2025)	Cost of goods ¥33.2b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €70.9m (FY, 2025)	Gross profit ¥60.8b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income (€3.5m) (FY, 2025)	Net income ¥13.9b (FY, 2025)